Vista Pharmaceuticals Limited (VISTAPH.BO)
INR 11.08
(2.12%)
INR 11.08
(2.12%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 78.7 Million INR | -19.82% |
| 2022 | 98.16 Million INR | -21.72% |
| 2021 | 125.4 Million INR | 17.94% |
| 2020 | 106.32 Million INR | -30.52% |
| 2019 | 153.02 Million INR | 38.49% |
| 2018 | 110.5 Million INR | 10.11% |
| 2017 | 100.35 Million INR | 78.56% |
| 2016 | 56.2 Million INR | -24.86% |
| 2015 | 74.79 Million INR | 89.82% |
| 2014 | 39.4 Million INR | 4204.76% |
| 2013 | -959.91 Thousand INR | 46.63% |
| 2012 | -1.79 Million INR | 4.27% |
| 2011 | -1.87 Million INR | -230.29% |
| 2010 | -568.87 Thousand INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q3 | 2.42 Million INR | -97.32% |
| 2023 FY | 78.7 Million INR | -19.82% |
| 2023 Q4 | 78.7 Million INR | 3152.23% |
| 2023 Q2 | 90.14 Million INR | 12316.12% |
| 2023 Q1 | 726 Thousand INR | -99.26% |
| 2022 Q4 | 98.16 Million INR | 13571.45% |
| 2022 Q3 | 718 Thousand INR | -99.46% |
| 2022 FY | 98.16 Million INR | -21.72% |
| 2022 Q2 | 133.23 Million INR | 18431.15% |
| 2022 Q1 | 719 Thousand INR | -99.43% |
| 2021 Q4 | 125.4 Million INR | 16938.18% |
| 2021 Q2 | 159.39 Million INR | 11277.15% |
| 2021 FY | 125.4 Million INR | 17.94% |
| 2021 Q1 | 1.4 Million INR | -98.68% |
| 2021 Q3 | 736 Thousand INR | -99.54% |
| 2020 Q3 | 112.86 Million INR | -3.54% |
| 2020 Q4 | 106.32 Million INR | -5.79% |
| 2020 Q1 | 1.64 Million INR | -98.93% |
| 2020 FY | 106.32 Million INR | -30.52% |
| 2020 Q2 | 117 Million INR | 7025.46% |
| 2019 Q4 | 153.02 Million INR | 1590.18% |
| 2019 FY | 153.02 Million INR | 38.49% |
| 2019 Q1 | 8.67 Million INR | -92.15% |
| 2019 Q3 | 9.05 Million INR | -90.9% |
| 2019 Q2 | 99.44 Million INR | 1046.06% |
| 2018 Q1 | 17.87 Million INR | -82.28% |
| 2018 FY | 110.5 Million INR | 10.11% |
| 2018 Q3 | 2.14 Million INR | -98.2% |
| 2018 Q4 | 110.5 Million INR | 5054.01% |
| 2018 Q2 | 119.1 Million INR | 566.15% |
| 2017 Q3 | 13.56 Million INR | -88.91% |
| 2017 FY | 100.35 Million INR | 78.56% |
| 2017 Q4 | 100.87 Million INR | 643.55% |
| 2017 Q2 | 122.33 Million INR | 113.11% |
| 2017 Q1 | 57.4 Million INR | 1.16% |
| 2016 Q1 | 4.32 Million INR | -94.22% |
| 2016 FY | 56.2 Million INR | -24.86% |
| 2016 Q4 | 56.74 Million INR | -17.58% |
| 2016 Q3 | 68.85 Million INR | 0.17% |
| 2016 Q2 | 68.73 Million INR | 1490.35% |
| 2015 Q1 | 969.79 Thousand INR | -97.54% |
| 2015 FY | 74.79 Million INR | 89.82% |
| 2015 Q2 | 74.74 Million INR | 7607.08% |
| 2015 Q4 | 74.79 Million INR | -11.19% |
| 2015 Q3 | 84.21 Million INR | 12.67% |
| 2014 Q1 | 490.91 Thousand INR | 151.14% |
| 2014 Q2 | -2.59 Million INR | -629.41% |
| 2014 FY | 39.4 Million INR | 4204.76% |
| 2014 Q4 | 39.4 Million INR | 6332.94% |
| 2014 Q3 | -632.16 Thousand INR | 75.68% |
| 2013 Q1 | 1.32 Million INR | 173.93% |
| 2013 Q4 | -959.91 Thousand INR | 0.0% |
| 2013 FY | -959.91 Thousand INR | 46.63% |
| 2012 FY | -1.79 Million INR | 4.27% |
| 2012 Q4 | -1.79 Million INR | 0.0% |
| 2011 FY | -1.87 Million INR | -230.29% |
| 2011 Q4 | -1.87 Million INR | 0.0% |
| 2010 FY | -568.87 Thousand INR | 0.0% |
| 2010 Q4 | -568.87 Thousand INR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| ANG Lifesciences India Limited | 671.01 Million INR | 88.271% |
| Add-Shop E-Retail Limited | 116.24 Million INR | 32.296% |
| Bacil Pharma Limited | 569 Thousand INR | -13731.986% |
| Beryl Drugs Limited | 48.7 Million INR | -61.583% |
| Cian Healthcare Limited | 544.97 Million INR | 85.558% |
| Colinz Laboratories Limited | -64.3 Million INR | 222.396% |
| Concord Drugs Limited | 164.48 Million INR | 52.152% |
| Deccan Health Care Limited | -7.07 Million INR | 1212.267% |
| Gennex Laboratories Limited | -552.54 Million INR | 114.244% |
| Gujarat Terce Laboratories Limited | 37.76 Million INR | -108.41% |
| Ishita Drugs and Industries Limited | -48.09 Million INR | 263.633% |
| Kerala Ayurveda Limited | 447.82 Million INR | 82.425% |
| Kwality Pharmaceuticals Limited | 921.75 Million INR | 91.461% |
| Mercury Laboratories Limited | -26.72 Million INR | 394.452% |
| Panchsheel Organics Limited | -157.82 Million INR | 149.869% |
| Parmax Pharma Limited | 51.8 Million INR | -51.909% |
| Parnax Lab Limited | 787.61 Million INR | 90.007% |
| Patidar Buildcon Limited | 25.12 Million INR | -213.237% |
| Pharmaids Pharmaceuticals Limited | 37.28 Million INR | -111.071% |
| Phaarmasia Limited | -4.89 Million INR | 1707.188% |
| Sandu Pharmaceuticals Limited | -11.43 Million INR | 788.574% |
| Sastasundar Ventures Limited | -297.24 Million INR | 126.477% |
| SHELTER PHARMA LIMITED | -44.62 Million INR | 276.371% |
| Source Natural Foods and Herbal Supplements Limited | -58.58 Million INR | 234.339% |
| SUDARSHAN PHARMA INDUSTRIES LI | 1.04 Billion INR | 92.482% |
| Sunil Healthcare Limited | 625.4 Million INR | 87.415% |
| Syschem (India) Limited | 3.53 Million INR | -2128.313% |
| Trident Lifeline Limited | 117.56 Million INR | 33.052% |
| Transchem Limited | -3.16 Million INR | 2588.271% |
| Tyche Industries Limited | -788.94 Million INR | 109.976% |
| Vikram Thermo (India) Limited | 38.62 Million INR | -103.764% |
| Vasundhara Rasayans Limited | -76.15 Million INR | 203.35% |
| Zenith Healthcare Limited | -25.45 Million INR | 409.164% |
| Zenotech Laboratories Limited | -196.85 Million INR | 139.98% |
| Hindustan Bio Sciences Limited | 25.21 Million INR | -212.152% |
| KIMIA BIOSCIENCES LIMITED | 431.72 Million INR | 81.77% |
| Chemo Pharma Laboratories Limited | -6.05 Million INR | 1399.175% |
| MedPlus Health Services Limited | 8.67 Billion INR | 99.093% |
| Sanjivani Paranteral Limited. | -85.95 Million INR | 191.57% |
| Smruthi Organics Limited | 111.28 Million INR | 29.28% |
| Trimurthi Limited | -1.17 Million INR | 6780.02% |
| Zenlabs Ethica Limited | 139.54 Million INR | 43.6% |
| Makers Laboratories Limited | 172.59 Million INR | 54.399% |
| Lactose (India) Limited | 373.97 Million INR | 78.955% |
| Bharat Immunologicals & Biologicals Corporation Limited | 689.39 Million INR | 88.584% |
| Roopa Industries Limited | 216.01 Million INR | 63.565% |
| PANJON LTD. | -12.8 Million INR | 714.491% |
| TIAAN CONSUMER LIMITED | 13.44 Million INR | -485.377% |
| Anuh Pharma Limited | -69.8 Million INR | 212.745% |
| Crestchem Limited | -1.45 Million INR | 5527.862% |
| Emmessar Biotech & Nutrition Limited | -60.73 Million INR | 229.592% |
| PRAVEG LIMITED | -434.98 Million INR | 118.093% |
| Fredun Pharmaceuticals Limited | 1.04 Billion INR | 92.461% |
| Shukra Pharmaceuticals Limited | -68.26 Million INR | 215.292% |
| Norris Medicines Limited | 214.86 Million INR | 63.37% |
| Denis Chem Lab Limited | -236.28 Million INR | 133.309% |
| Veerhealth Care Limited | -2.38 Million INR | 3399.958% |
| Jenburkt Pharmaceuticals Limited | -791.91 Million INR | 109.938% |
| OXYGENTA PHARMACEUTICAL LIMITE | 571.32 Million INR | 86.224% |
| Godavari Drugs Limited | 530.02 Million INR | 85.151% |
| SHAMROCK INDUSTRIAL CO.LTD. | -9.31 Million INR | 945.371% |
| Ambalal Sarabhai Enterprises Limited | 132.1 Million INR | 40.421% |
| Vivanza Biosciences Limited | 50.02 Million INR | -57.326% |
| Medi-Caps Limited | -3.21 Million INR | 2548.787% |
| DECIPHER LABS LIMITED | -93.13 Million INR | 184.503% |
| Shree Ganesh Remedies Limited | 201.85 Million INR | 61.01% |
| Gujarat Themis Biosyn Limited | -53.88 Million INR | 246.062% |
| Bharat Parenterals Limited | 1.48 Billion INR | 94.713% |
| BDH Industries Limited | -164.47 Million INR | 147.853% |
| Coral Laboratories Limited | -612.82 Million INR | 112.843% |
| Evoq Remedies Limited | 41.14 Million INR | -91.271% |
| Trinity League India Limited | -12 Thousand INR | 655966.667% |
| KOBO BIOTECH LIMITED | 1.39 Billion INR | 94.359% |
| Natural Capsules Limited | 956.68 Million INR | 91.773% |
| Auro Laboratories Limited | 252.51 Million INR | 68.832% |